These strategies included: (1) screening all pregnant women for c

These strategies included: (1) screening all pregnant women for chronic hepatitis B infection; Once the sub-committee compiles and reviews the epidemiological, vaccine, and economic data and hears from KCDC and external experts, members try to reach a consensus on recommendations

concerning control measures for the disease in question, including immunization; target groups for vaccination; route of administration; and other key considerations. If the sub-committee cannot reach a consensus, it is the prerogative of the Chairperson to decide what recommendations to give to the KACIP. A senior officer from Selleck I BET151 the KCDC summarizes the data, opinions and recommendations coming from the sub-committee and includes this information in a bound document prepared for KACIP members for each meeting. This document also includes information and views from KCDC and other (non-industry) experts,

as well as the meeting agenda, recommendations from the previous meeting, and the terms of reference of the Committee. During the meetings of the KACIP, experts, including ex-officio members, officials from the KFDA or the KCDC or members of the relevant sub-committee, give presentations or are asked to express their views. Members then discuss each issue in depth and develop recommendations, usually by consensus. An officer of the KCDC records the recommendations or other results of the meeting, which the KACIP Chairperson submits

to the Director of the KCDC, who in turn transmits the recommendations to the MoH. Selleckchem Y 27632 The minutes of the KACIP meetings are given to the KCDC Director and other staff, but are not made public. While most decisions made by the Committee are approved by the MoH and thus implemented, KACIP recommendations are not legally binding, and there have been times where recommendations were not implemented for some time due to a lack of funding or the need to revise laws in order to enact the policy change. For example, the program recommended by the KACIP to subsidize MycoClean Mycoplasma Removal Kit part of the costs of EPI vaccines administered at private health facilities (described above) required that the Prevention of Contagious Diseases Act be revised, before it could be implemented. If a recommendation is approved by the MoH, officials of the KCDC then develop a budget to cover the costs of the new policy change (e.g., the introduction of a new vaccine), and plan the steps necessary to implement the recommendation, working with both public and private health facilities and organizations. The Public Relations Department of the KCDC then prepares public education materials, such as brochures, posters, and vaccine information statements or factsheets to alert the public and medical community of the new recommendations.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>